ACADIA Pharmaceuticals Inc.

Historical 13F Holders

Symbol
ACAD
CUSIP
004225108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 004225108 since 12/18/2024, largest first.

Filer % of Class Filed
Baker Bros. Advisors LP 13D/A
25.4% 2/26/2026
Event 2/24/2026
BlackRock, Inc. 13G/A 11.9% 2/7/2025
Event 1/31/2025
State Street Corp 13G 5.3% 8/7/2026
Event 6/30/2026
Vanguard Portfolio Management LLC 13G 5.2% 4/28/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
RTW Investments, LP 13G/A
4.2% 11/14/2025
Event 9/30/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 34 1.08 M $21.8 M
2026 Q2 370 172 M $4.40 B
2026 Q1 364 165 M $3.67 B
2025 Q4 355 166 M $4.44 B
2025 Q3 362 168 M $3.59 B
2025 Q2 334 173 M $3.73 B
2025 Q1 340 173 M $2.87 B
2024 Q4 310 163 M $3.00 B
2024 Q3 274 157 M $2.41 B
2024 Q2 286 164 M $2.67 B
2024 Q1 303 166 M $3.07 B
2023 Q4 305 163 M $5.09 B
2023 Q3 274 156 M $3.26 B
2023 Q2 251 159 M $3.81 B
2023 Q1 252 158 M $2.98 B
2022 Q4 246 164 M $2.88 B
2022 Q3 240 153 M $2.50 B
2022 Q2 268 151 M $2.13 B
2022 Q1 286 148 M $3.58 B
2021 Q4 278 150 M $3.51 B
2021 Q3 256 145 M $2.41 B
2021 Q2 262 148 M $3.61 B
2021 Q1 313 147 M $3.79 B
2020 Q4 331 148 M $7.93 B
2020 Q3 295 150 M $6.19 B
2020 Q2 322 153 M $7.41 B
2020 Q1 268 155 M $6.56 B
2019 Q4 304 152 M $6.48 B
2019 Q3 263 148 M $5.32 B
2019 Q2 224 139 M $3.72 B
2019 Q1 221 138 M $3.70 B
2018 Q4 209 141 M $2.28 B
2018 Q3 214 123 M $2.56 B
2018 Q2 213 119 M $1.82 B
2018 Q1 218 124 M $2.78 B
2017 Q4 234 120 M $3.62 B
2017 Q3 242 118 M $4.45 B
2017 Q2 228 120 M $3.34 B
2017 Q1 246 120 M $4.12 B
2016 Q4 270 121 M $3.50 B
2016 Q3 267 118 M $3.75 B
2016 Q2 257 111 M $3.61 B
2016 Q1 261 111 M $3.09 B
2015 Q4 244 102 M $3.64 B
2015 Q3 210 101 M $3.39 B
2015 Q2 212 98.3 M $4.12 B
2015 Q1 214 97.3 M $3.17 B
2014 Q4 201 96.9 M $3.08 B
2014 Q3 185 94.2 M $2.33 B
2014 Q2 182 97.4 M $2.20 B
2014 Q1 191 90.9 M $2.21 B